BMO Capital Maintains Market Perform on Amgen, Lowers Price Target to $415

Benzinga · 2d ago
BMO Capital analyst Evan David Seigerman maintains Amgen (NASDAQ:AMGN) with a Market Perform and lowers the price target from $450 to $415.